Broos CE, et al. - The purpose of this research was to delineate the impact of different doses of prednisone on forced vital capacity (FVC) and weight in treatment naïve pulmonary sarcoidosis patients in daily practice. Findings indicated that using a treatment regimen characterized by early dose tapering, the dose of prednisone therapy aimed at improving or preserving FVC in newly treated pulmonary sarcoidosis can often be reduced.